Pharma Foods International Co., Ltd.
PMDSF
$6.24
$0.643211.50%
OTC PK
| 01/31/2025 | 07/31/2024 | 04/30/2024 | 01/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | 98.65M | 95.34M | 102.75M | 105.94M | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 98.65M | 95.34M | 102.75M | 105.94M | |
| Cost of Revenue | 18.60M | 22.45M | 21.97M | 21.36M | |
| Gross Profit | 80.05M | 72.90M | 80.78M | 84.58M | |
| SG&A Expenses | 79.69M | 59.28M | 67.73M | 76.53M | |
| Depreciation & Amortization | 213.30K | 114.60K | 119.20K | 273.20K | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 100.45M | 83.59M | 91.29M | 99.56M | |
| Operating Income | -1.80M | 11.76M | 11.46M | 6.38M | |
| Income Before Tax | -1.57M | 11.46M | 11.20M | 6.41M | |
| Income Tax Expenses | -724.00K | 2.87M | 3.99M | 3.11M | |
| Earnings from Continuing Operations | -846.80K | 8.59M | 7.20M | 3.29M | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -846.80K | 8.59M | 7.20M | 3.29M | |
| EBIT | -1.80M | 11.76M | 11.46M | 6.38M | |
| EBITDA | -568.80K | 13.20M | 12.36M | 7.46M | |
| EPS Basic | -0.03 | 0.31 | 0.26 | 0.11 | |
| Normalized Basic EPS | -0.04 | 0.29 | 0.25 | 0.14 | |
| EPS Diluted | -0.03 | 0.31 | 0.26 | 0.11 | |
| Normalized Diluted EPS | -0.04 | 0.29 | 0.25 | 0.14 | |
| Average Basic Shares Outstanding | 28.96M | 28.07M | 28.08M | 28.77M | |
| Average Diluted Shares Outstanding | 28.96M | 28.07M | 28.08M | 28.77M | |
| Dividend Per Share | 0.08 | 0.10 | 0.00 | 0.07 | |
| Payout Ratio | -- | -- | -- | -- | |